23 related articles for article (PubMed ID: 1060605)
1. Hepatoprotective effect of nanoniosome loaded Myristica fragrans phenolic compounds in mice-induced hepatotoxicity.
Poorbagher MRM; Karimi E; Oskoueian E
J Cell Mol Med; 2022 Nov; 26(21):5517-5527. PubMed ID: 36226354
[TBL] [Abstract][Full Text] [Related]
2. [Immunological aspects in the L-asparaginase treatment of children with lymphoproliferative diseases].
Zajaçzkowski J; Halikowski B; Pituch A; Legutko L; Pajdak E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(1):21-8. PubMed ID: 58815
[TBL] [Abstract][Full Text] [Related]
3. [Results of repeated L-asparaginase treatment in acute lymphoblastic leukemia and lymphosarcoma in children].
Zajaczkowski J; Legutko L; Armata J; Halikowska-łacka E
Pediatr Pol; 1975 Aug; 50(8):985-90. PubMed ID: 1057762
[No Abstract] [Full Text] [Related]
4. Immunoglobulin and granulocyte cytochemical reactions in L-asparaginase treated children with acute lymphoblastic leukemia.
Zajaczkowski L; Pituch A; Legutko L
Med Interne; 1976; 14(3):191-5. PubMed ID: 1071477
[TBL] [Abstract][Full Text] [Related]
5. [Repeated, 2-10 fold asparaginase treatments in children with lymphoproliferative diseases].
Legutko L; Zajaczkowski J; Halikowska-Lacka E; Pituch A; Cyklis R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(5):644-50. PubMed ID: 64404
[TBL] [Abstract][Full Text] [Related]
6. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
[TBL] [Abstract][Full Text] [Related]
7. [Significance of L-asparaginase activity and biochemical parameters evaluation in children with acute lymphoblastic leukemia].
Pawińska K; Balwierz W; Sztefko K; Czogała M
Przegl Lek; 2006; 63(1):44-6. PubMed ID: 16892900
[TBL] [Abstract][Full Text] [Related]
8. [L-asparaginase and leukemia].
Grundmann E
Klin Wochenschr; 1969 Jan; 47(2):61-4. PubMed ID: 4904781
[No Abstract] [Full Text] [Related]
9. L-asparaginase.
Capizzi RL; Bertino JR; Handschumacher RE
Annu Rev Med; 1970; 21():433-44. PubMed ID: 4913953
[No Abstract] [Full Text] [Related]
10. L-Asparaginase: human toxicology and single agent activity in nonleukemic neoplasms.
Haskell CM
Cancer Treat Rep; 1981; 65 Suppl 4():57-9. PubMed ID: 7049381
[TBL] [Abstract][Full Text] [Related]
11. Immunological aspects of L-asparaginase treatment in children with lymphoproliferative disease.
Zajaczkowski J; Pituch A; Legutko L; Pajak E
Helv Paediatr Acta; 1976 Jan; 30(4-5):441-6. PubMed ID: 1060605
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
